QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
Clinical trial NCT04864782 · TERMINATED
Trial details
- NCT number
- NCT04864782
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2022-09-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.